Aptose Biosciences Inc. (APTO) DCF Valuation

Aptose Biosciences Inc. (APTO) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Aptose Biosciences Inc. (APTO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategy with the Aptose Biosciences Inc. (APTO) DCF Calculator! Explore authentic financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Aptose Biosciences Inc. (APTO).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -26.3 -57.5 -64.2 -39.7 -52.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .6 .6 .6 .5 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -26.9 -58.2 -64.8 -40.2 -52.4 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 97.6 122.4 79.1 47.0 9.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.0 2.2 1.7 6.3 6.0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 -.1 -.2 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -26.3 -57.6 -64.7 -39.4 -52.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -23.8 -56.8 -64.8 -34.3 -52.6 -6.0 .0 .0 .0 .0
WACC, % 8.38 8.4 8.41 8.38 8.42 8.4 8.4 8.4 8.4 8.4
PV UFCF
SUM PV UFCF -5.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -6
Net Debt -8
Equity Value 3
Diluted Shares Outstanding, MM 7
Equity Value Per Share 0.39

What You Will Receive

  • Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-loaded real APTO financials.
  • Accurate Data: Historical performance data and future projections (highlighted in the yellow cells).
  • Assumption Flexibility: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect Aptose’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Layout: Organized for clarity and ease of navigation, complete with step-by-step guidance.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical performance metrics and future forecasts for Aptose Biosciences Inc. (APTO).
  • Adjustable Projection Parameters: Modify highlighted fields such as WACC, expected growth rates, and profit margins.
  • Real-Time Financial Calculations: Automatic recalculations for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Visual Interface: Intuitive charts and summaries for clear visualization of your financial analyses.
  • Designed for All Levels: An accessible layout tailored for investors, financial officers, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Aptose Biosciences Inc.'s pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you adjust your assumptions.
  5. Step 5: Analyze the outputs and utilize the results for your investment decisions.

Why Choose This Calculator for Aptose Biosciences Inc. (APTO)?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for biotech firms.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for APTO.
  • Detailed Insights: Automatically computes Aptose's intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and biotech consultants focusing on APTO.

Who Should Use This Product?

  • Investors: Accurately assess Aptose Biosciences Inc.'s (APTO) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Aptose Biosciences Inc. (APTO).
  • Consultants: Efficiently customize the template for valuation reports tailored to Aptose Biosciences Inc. (APTO) clients.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms like Aptose Biosciences Inc. (APTO).
  • Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to the biotech sector.

What the Template Contains

  • Preloaded APTO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.